Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
Background Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistoch...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2019-05-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2019-02-03.pdf |
_version_ | 1818153933592330240 |
---|---|
author | Jung-Soo Pyo Nae Yu Kim Won Jin Cho |
author_facet | Jung-Soo Pyo Nae Yu Kim Won Jin Cho |
author_sort | Jung-Soo Pyo |
collection | DOAJ |
description | Background Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis. Methods The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted. Results Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS. Conclusions Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice. |
first_indexed | 2024-12-11T14:18:29Z |
format | Article |
id | doaj.art-a726bf6edf614c1898ccc90dd81c72b9 |
institution | Directory Open Access Journal |
issn | 2383-7837 2383-7845 |
language | English |
last_indexed | 2024-12-11T14:18:29Z |
publishDate | 2019-05-01 |
publisher | Korean Society of Pathologists & the Korean Society for Cytopathology |
record_format | Article |
series | Journal of Pathology and Translational Medicine |
spelling | doaj.art-a726bf6edf614c1898ccc90dd81c72b92022-12-22T01:03:03ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452019-05-0153317317910.4132/jptm.2019.02.0316823Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-AnalysisJung-Soo PyoNae Yu Kim0Won Jin Cho1 Departments of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea Department of Urology, Chosun University Hospital, Chosun University School of Medicine, Gwangju, KoreaBackground Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis. Methods The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted. Results Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS. Conclusions Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.http://www.jpatholtm.org/upload/pdf/jptm-2019-02-03.pdfClaudin-1ImmunohistochemistryPrognosisMalignancyMeta-analysis |
spellingShingle | Jung-Soo Pyo Nae Yu Kim Won Jin Cho Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis Journal of Pathology and Translational Medicine Claudin-1 Immunohistochemistry Prognosis Malignancy Meta-analysis |
title | Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis |
title_full | Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis |
title_fullStr | Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis |
title_full_unstemmed | Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis |
title_short | Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis |
title_sort | prognostic role of claudin 1 immunohistochemistry in malignant solid tumors a meta analysis |
topic | Claudin-1 Immunohistochemistry Prognosis Malignancy Meta-analysis |
url | http://www.jpatholtm.org/upload/pdf/jptm-2019-02-03.pdf |
work_keys_str_mv | AT jungsoopyo prognosticroleofclaudin1immunohistochemistryinmalignantsolidtumorsametaanalysis AT naeyukim prognosticroleofclaudin1immunohistochemistryinmalignantsolidtumorsametaanalysis AT wonjincho prognosticroleofclaudin1immunohistochemistryinmalignantsolidtumorsametaanalysis |